US Unveils Sweeping New National Plan to Fight Alzheimer's and Dementia
The US Department of Health and Human Services released a major update to its national Alzheimer's strategy on 22 October 2026, restructuring it around four new goals — including prevention and earlier detection — with ARPA-H committing up to US$48.8 million in new awards toward earlier detection and intervention, bringing its total Alzheimer's investment to as much as US$155.3 million.
On 22 October 2026, the US Department of Health and Human Services published the 2026 Update to the National Plan to Address Alzheimer's Disease and Related Dementias, the most significant revision of the strategy in years. The update replaces the plan's six historical goals with four new ones: reducing dementia risk across the lifespan, speeding up discovery and innovation in prevention and treatment, improving care from diagnosis through transitions, and strengthening services for patients and families. Ten HHS agencies are coordinating initiatives tied to the plan. The FDA launched an Alzheimer's Prevention Accelerator, and the Advanced Research Projects Agency for Health (ARPA-H) committed up to US$48.8 million in new awards focused on earlier detection and intervention. Those awards join existing complementary ARPA-H efforts, bringing the agency's total Alzheimer's investment to as much as US$155.3 million. The plan also calls for expanding dementia screening and staff training in federally funded health centres and piloting a lifestyle-intervention programme for Medicare beneficiaries showing signs of mild cognitive impairment. The announcement comes as the number of Americans living with Alzheimer's is projected to rise sharply over coming decades with the ageing of the baby-boomer generation.
